BIOMAT Database Logo BIOMAT Database Logo

Use of cyclosporin in lupus nephritis. 1995

J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Columbia University College of Physicians and Surgeons, New York, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008181 Lupus Nephritis Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). Glomerulonephritis, Lupus,Lupus Glomerulonephritis,Nephritis, Lupus,Glomerulonephritides, Lupus,Lupus Glomerulonephritides,Lupus Nephritides,Nephritides, Lupus
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Long-term treatment of lupus nephritis with cyclosporin A.
August 1998, QJM : monthly journal of the Association of Physicians,
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Sustained remission in a case of lupus nephritis with cyclosporin therapy.
January 2001, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A.
January 2001, Lupus,
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
WITHDRAWN: Use of mycophenolic acid in lupus nephritis.
January 2013, Clinical immunology (Orlando, Fla.),
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis.
August 1997, British journal of clinical pharmacology,
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
[A clinical study on low dose cyclosporin A in the treatment of lupus nephritis].
October 1994, Zhonghua nei ke za zhi,
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Lupus nephritis: MAINTAINing perspective in lupus nephritis trials.
July 2015, Nature reviews. Nephrology,
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Lupus nephritis: Mesenchymal stromal cells in lupus nephritis.
July 2017, Nature reviews. Nephrology,
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
February 2000, Rheumatology (Oxford, England),
J Radhakrishnan, and A Valeri, and C Kunis, and G B Appel
Successful use of cyclosporin A in progressive anti-glomerular basement membrane nephritis.
October 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!